Published in Thromb J on May 09, 2011
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet (1994) 5.58
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood (1995) 2.96
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood (1998) 1.47
Factor V Leiden and hemophilia. Thromb Res (2009) 1.02
Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography. Thromb Haemost (2000) 0.96
Aortic intimal injuries from blunt trauma: resolution profile in nonoperative management. J Trauma (2002) 0.94
Decision analysis model of prolonged oral anticoagulant treatment in factor V Leiden carriers with first episode of deep vein thrombosis. BMJ (1998) 0.92
Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction. Am Heart J (2004) 0.90
Aortic arch thrombosis in a neonate with heterozygous carrier status of factor V Leiden mutation. Congenit Heart Dis (2006) 0.89
Extensive arterial thrombosis in a patient with factor V Leiden mutation. Interact Cardiovasc Thorac Surg (2010) 0.87
Arterial thrombosis associated with heterozygous factor V Leiden disorder, hyperhomocysteinemia, and peripheral arterial disease: importance of synergistic factors. J Vasc Surg (2005) 0.87
Arterial embolism to the upper extremity in a patient with factor V Leiden mutation (APC resistance)--a case report and review of the literature. Angiology (2003) 0.85
Stent-assisted recanalisation of acute occlusive arteries in patients with acute limb ischaemia. Eur J Vasc Endovasc Surg (2009) 0.85
[Traumatic unilateral renal artery thrombosis and protein C deficiency. A case report]. J Mal Vasc (2006) 0.79
Is homozygosity for factor V Leiden a risk factor for myocardial infarction in young women who smoke? Thromb Haemost (2005) 0.79
Catastrophic arterial thromboembolism associated with factor V Leiden. Eur J Vasc Endovasc Surg (2000) 0.78
Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med (2003) 4.94
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother (2007) 3.66
Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients*. Crit Care Med (2014) 2.86
Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. Chest (2013) 2.32
An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis (2010) 2.26
Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med (2007) 2.14
Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg (2008) 2.10
Soluble triggering receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis. Intensive Care Med (2006) 2.07
Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill. Antimicrob Agents Chemother (2012) 1.88
Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med (2010) 1.79
High incidence of neuroendocrine dysfunction in long-term survivors of aneurysmal subarachnoid hemorrhage. Stroke (2004) 1.76
Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis. Crit Care Med (2009) 1.76
Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. J Cancer Res Clin Oncol (2007) 1.60
Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care (2010) 1.55
The importance of religious affiliation and culture on end-of-life decisions in European intensive care units. Intensive Care Med (2007) 1.52
Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis (2006) 1.52
Impact of passive humidification on clinical outcomes of mechanically ventilated patients: a meta-analysis of randomized controlled trials. Crit Care Med (2007) 1.50
The world's major religions' points of view on end-of-life decisions in the intensive care unit. Intensive Care Med (2007) 1.43
Acute vasodilator responsiveness and microvascular recruitment in idiopathic pulmonary arterial hypertension. Ann Intern Med (2015) 1.42
Early apoptosis of blood monocytes in the septic host: is it a mechanism of protection in the event of septic shock? Crit Care (2006) 1.41
Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. Clin Infect Dis (2008) 1.37
Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infection. Intensive Care Med (2008) 1.36
Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study. Invest New Drugs (2005) 1.34
Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital. Clin Infect Dis (2008) 1.32
Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens. J Infect (2009) 1.23
Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med (2009) 1.21
Pretreatment with atorvastatin attenuates lung injury caused by high-stretch mechanical ventilation in an isolated rabbit lung model. Crit Care Med (2010) 1.20
Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis. Cytokine (2007) 1.20
Plasma pro- and anti-inflammatory cytokine levels and outcome prediction in unselected critically ill patients. Cytokine (2008) 1.16
Old antibiotics for infections in critically ill patients. Curr Opin Crit Care (2007) 1.14
An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med (2012) 1.12
Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study. Crit Care (2009) 1.07
The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk. Thromb Res (2007) 1.06
Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor. Crit Care (2012) 1.03
Adjunctive therapies for community-acquired pneumonia: a systematic review. J Antimicrob Chemother (2008) 1.03
Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population. Shock (2009) 1.02
Serial changes in adiponectin and resistin in critically ill patients with sepsis: associations with sepsis phase, severity, and circulating cytokine levels. J Crit Care (2012) 1.01
Angiopoietin-2 is increased in septic shock: evidence for the existence of a circulating factor stimulating its release from human monocytes. Immunol Lett (2009) 1.01
Inhaled activated protein C protects mice from ventilator-induced lung injury. Crit Care (2010) 1.00
Invasive aspergillosis in the intensive care unit. Ann N Y Acad Sci (2012) 0.98
The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS. Thromb Res (2008) 0.96
Prone positioning in hypoxemic respiratory failure: meta-analysis of randomized controlled trials. J Crit Care (2008) 0.96
Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies. Br J Clin Pharmacol (2007) 0.95
Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice. Vascul Pharmacol (2006) 0.95
Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay. BMC Infect Dis (2009) 0.92
Acrometastases. Eur J Orthop Surg Traumatol (2013) 0.91
Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension. Arthritis Rheum (2008) 0.91
Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis. J Crit Care (2010) 0.91
Topoisomerase I and IIalpha protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy. Cancer Chemother Pharmacol (2008) 0.90
Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration. Antimicrob Agents Chemother (2012) 0.88
Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial. J Antimicrob Chemother (2013) 0.88
Prevalence and predictors of tuberculin skin positivity in Hellenic Army recruits. BMC Infect Dis (2006) 0.87
Static and dynamic mechanics of the murine lung after intratracheal bleomycin. BMC Pulm Med (2011) 0.87
Cancer chemoprevention: a summary of the current evidence. Anticancer Res (2008) 0.87
Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome. BMC Infect Dis (2014) 0.86
Treatment of invasive candidiasis in the elderly: a review. Clin Interv Aging (2013) 0.86
Venous oxygen saturation and lactate gradient from superior vena cava to pulmonary artery in patients with septic shock. Shock (2009) 0.86
Ex-vivo effect of dexamethasone on cytokine production from whole blood of septic patients: correlation with disease severity. Cytokine (2009) 0.85
Endocrine alterations in critically ill patients with stroke during the early recovery period. Neurocrit Care (2005) 0.85
Linezolid use associated with lactic acidosis. Scand J Infect Dis (2005) 0.85
How to select an antifungal agent in critically ill patients. J Crit Care (2013) 0.84
Short-term administration of a high oxygen concentration is not injurious in an ex-vivo rabbit model of ventilator-induced lung injury. Anesth Analg (2009) 0.84
Kinetics of progenitor hemopoetic stem cells in sepsis: correlation with patients survival? BMC Infect Dis (2006) 0.84
Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. Blood (2012) 0.84
Thyroid function changes and cytokine alterations following major surgery. Neuroimmunomodulation (2007) 0.83
Metformin attenuates ventilator-induced lung injury. Crit Care (2012) 0.83
TREM-1 expression on neutrophils and monocytes of septic patients: relation to the underlying infection and the implicated pathogen. BMC Infect Dis (2011) 0.83
Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot study. Pain Med (2008) 0.83
General prognostic scores in outcome prediction for cancer patients admitted to the intensive care unit. Am J Crit Care (2011) 0.82
A critical role for gelsolin in ventilator-induced lung injury. Am J Respir Cell Mol Biol (2009) 0.82
Pulmonary nocardiosis in an immunocompetent patient with COPD: the role of defective innate response. Heart Lung (2013) 0.81
Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia. Blood Coagul Fibrinolysis (2011) 0.81
Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome. Crit Care (2013) 0.81
Impact of the proton pump inhibitors and CYP2C19*2 polymorphism on platelet response to clopidogrel as assessed by four platelet function assays. Thromb Res (2013) 0.81
Antimicrobial activity of copper surfaces against carbapenemase-producing contemporary Gram-negative clinical isolates. J Antimicrob Chemother (2012) 0.81
Pleural effusion causing cardiac tamponade: report of two cases and review of the literature. Heart Lung (2006) 0.80
The effect of four hemostatic gene polymorphisms on the outcome of septic critically ill patients. Blood Coagul Fibrinolysis (2010) 0.80
Exhaled breath condensate in mechanically ventilated brain-injured patients with no lung injury or sepsis. Anesthesiology (2011) 0.80
Retinol-binding protein, acute phase reactants and Helicobacter pylori infection in patients with gastric adenocarcinoma. World J Gastroenterol (2005) 0.80
Serologic indices of hepatitis B virus infection in military recruits in Greece (2004-2005). BMC Infect Dis (2006) 0.80